Katherine Whittamore
University of Nottingham
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Katherine Whittamore.
Journal of the American Geriatrics Society | 2014
Katherine Whittamore; Sarah Goldberg; Lucy Bradshaw; Rowan H. Harwood
To identify patient and caregiver characteristics associated with caregiver dissatisfaction with hospital care of cognitively impaired elderly adults.
Health Technology Assessment | 2017
Peter Tyrer; Paul M. Salkovskis; Helen Tyrer; Duolao Wang; Mike J. Crawford; Simon Dupont; Sylvia Cooper; John C. Green; David Murphy; Georgina Smith; Sharandeep Bhogal; Shaeda Nourmand; Valentina Lazarevic; Gemma Loebenberg; Rachel Evered; Stephanie Kings; Antoinette McNulty; Yvonne Lisseman-Stones; Sharon McAllister; Kofi Kramo; Jessica Nagar; Steven Reid; Rahil Sanatinia; Katherine Whittamore; Gemma M. Walker; Aaron Philip; Hilary Warwick; Sarah Byford; Barbara Barrett
BACKGROUND Health anxiety is an under-recognised but frequent cause of distress that is potentially treatable, but there are few studies in secondary care. OBJECTIVE To determine the clinical effectiveness and cost-effectiveness of a modified form of cognitive-behaviour therapy (CBT) for health anxiety (CBT-HA) compared with standard care in medical outpatients. DESIGN Randomised controlled trial. SETTING Five general hospitals in London, Middlesex and Nottinghamshire. PARTICIPANTS A total of 444 patients aged 16-75 years seen in cardiology, endocrinology, gastroenterology, neurology and respiratory medicine clinics who scored ≥ 20 points on the Health Anxiety Inventory (HAI) and satisfied diagnostic requirements for hypochondriasis. Those with current psychiatric disorders were excluded, but those with concurrent medical illnesses were not. INTERVENTIONS Cognitive-behaviour therapy for health anxiety - between 4 and 10 1-hour sessions of CBT-HA from a health professional or psychologist trained in the treatment. Standard care was normal practice in primary and secondary care. MAIN OUTCOME MEASURES Primary - researchers masked to allocation assessed patients at baseline, 3, 6, 12, 24 months and 5 years. The primary outcome was change in the HAI score between baseline and 12 months. Main secondary outcomes - costs of care in the two groups after 24 and 60 months, change in health anxiety (HAI), generalised anxiety and depression [Hospital Anxiety and Depression Scale (HADS)] scores, social functioning using the Social Functioning Questionnaire and quality of life using the EuroQol-5 Dimensions (EQ-5D), at 6, 12, 24 and 60 months, and deaths over 5 years. RESULTS Of the 28,991 patients screened over 21 months, 5769 had HAI scores of ≥ 20 points. Improvement in HAI scores at 3 months was significantly greater in the CBT-HA group (mean number of sessions = 6) than in the standard care, and this was maintained over the 5-year period (overall p < 0.0001), with no loss of efficacy between 2 and 5 years. Differences in the generalised anxiety (p = 0.0018) and depression scores (p = 0.0065) on the HADS were similar in both groups over the 5-year period. Gastroenterology and cardiology patients showed the greatest CBT gains. The outcomes for nurses were superior to those of other therapists. Deaths (n = 24) were similar in both groups; those in standard care died earlier than those in CBT-HA. Patients with mild personality disturbance and higher dependence levels had the best outcome with CBT-HA. Total costs were similar in both groups over the 5-year period (£12,590.58 for CBT-HA; £13,334.94 for standard care). CBT-HA was not cost-effective in terms of quality-adjusted life-years, as measured using the EQ-5D, but was cost-effective in terms of HAI outcomes, and offset the cost of treatment. LIMITATIONS Many eligible patients were not randomised and the population treated may not be representative. CONCLUSIONS CBT-HA is a highly effective treatment for pathological health anxiety with lasting benefit over 5 years. It also improves generalised anxiety and depressive symptoms more than standard care. The presence of personality abnormality is not a bar to successful outcome. CBT-HA may also be cost-effective, but the high costs of concurrent medical illnesses obscure potential savings. This treatment deserves further research in medical settings. TRIAL REGISTRATION Current Controlled Trials ISRCTN14565822. FUNDING This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 50. See the NIHR Journals Library website for further project information.
Archive | 2015
John Gladman; Rowan Harwood; Simon Conroy; Pip Logan; Rachel Elliott; Rob Jones; Sarah Lewis; Jane Dyas; Justine Schneider; Davina Porock; Kristian Pollock; Sarah Goldberg; Judi Edmans; Adam Gordon; Lucy Bradshaw; Matthew Franklin; Katherine Whittamore; Isabella Robbins; Aidan Dunphy; Karen Spencer; Janet Darby; Lukasz Tanajewski; Vladislav Berdunov; Georgios Gkountouras; Pippa Foster; Nadia Frowd
International Journal of Nursing Studies | 2014
Sarah Goldberg; Katherine Whittamore; Kristian Pollock; Rowan H. Harwood; John Gladman
BMC Psychology | 2015
Peter Tyrer; Helen Tyrer; Sylvia Cooper; Barbara Barrett; Stephanie Kings; Valentina Lazarevic; Kate Bransby-Adams; Katherine Whittamore; Gemma M. Walker; Antoinette McNulty; Emma Donaldson; Luke Midgley; Shani McCoy; Rachel Evered; Min Yang; Boliang Guo; Yvonne Lisseman-Stones; Asmae Doukani; Roger T. Mulder; Richard Morriss; Mike Crawford
Archive | 2015
John Gladman; Rowan Harwood; Simon Conroy; Pip Logan; Rachel Elliott; Rob Jones; Sarah Lewis; Jane Dyas; Justine Schneider; Davina Porock; Kristian Pollock; Sarah Goldberg; Judi Edmans; Adam Gordon; Lucy Bradshaw; Matthew Franklin; Katherine Whittamore; Isabella Robbins; Aidan Dunphy; Karen Spencer; Janet Darby; Lukasz Tanajewski; Vladislav Berdunov; Georgios Gkountouras; Pippa Foster; Nadia Frowd
Archive | 2015
John Gladman; Rowan Harwood; Simon Conroy; Pip Logan; Rachel Elliott; Rob Jones; Sarah Lewis; Jane Dyas; Justine Schneider; Davina Porock; Kristian Pollock; Sarah Goldberg; Judi Edmans; Adam Gordon; Lucy Bradshaw; Matthew Franklin; Katherine Whittamore; Isabella Robbins; Aidan Dunphy; Karen Spencer; Janet Darby; Lukasz Tanajewski; Vladislav Berdunov; Georgios Gkountouras; Pippa Foster; Nadia Frowd
Archive | 2015
John Gladman; Rowan Harwood; Simon Conroy; Pip Logan; Rachel Elliott; Rob Jones; Sarah Lewis; Jane Dyas; Justine Schneider; Davina Porock; Kristian Pollock; Sarah Goldberg; Judi Edmans; Adam Gordon; Lucy Bradshaw; Matthew Franklin; Katherine Whittamore; Isabella Robbins; Aidan Dunphy; Karen Spencer; Janet Darby; Lukasz Tanajewski; Vladislav Berdunov; Georgios Gkountouras; Pippa Foster; Nadia Frowd
Archive | 2015
John Gladman; Rowan Harwood; Simon Conroy; Pip Logan; Rachel Elliott; Rob Jones; Sarah Lewis; Jane Dyas; Justine Schneider; Davina Porock; Kristian Pollock; Sarah Goldberg; Judi Edmans; Adam Gordon; Lucy Bradshaw; Matthew Franklin; Katherine Whittamore; Isabella Robbins; Aidan Dunphy; Karen Spencer; Janet Darby; Lukasz Tanajewski; Vladislav Berdunov; Georgios Gkountouras; Pippa Foster; Nadia Frowd
Archive | 2015
John Gladman; Rowan Harwood; Simon Conroy; Pip Logan; Rachel Elliott; Rob Jones; Sarah Lewis; Jane Dyas; Justine Schneider; Davina Porock; Kristian Pollock; Sarah Goldberg; Judi Edmans; Adam Gordon; Lucy Bradshaw; Matthew Franklin; Katherine Whittamore; Isabella Robbins; Aidan Dunphy; Karen Spencer; Janet Darby; Lukasz Tanajewski; Vladislav Berdunov; Georgios Gkountouras; Pippa Foster; Nadia Frowd